Cargando…
Therapeutic Potential of Biochanin A in Herpes Simplex Keratitis
Herpes simplex keratitis (HSK) is a blinding eye disease that is initiated by the herpes simplex virus type 1 (HSV-1). Resistance to acyclovir (ACV) and the side effects of corticosteroid drugs have become concerning issues, so it is crucial to develop new antivirals for treating HSK. In this study,...
Autores principales: | Zhou, Nan, Zheng, Deyuan, You, Qiao, Chen, Taige, Jiang, Jiaxuan, Shen, Wenhao, Zhang, Di, Liu, Junpeng, Chen, Deyan, Hu, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536220/ https://www.ncbi.nlm.nih.gov/pubmed/37765049 http://dx.doi.org/10.3390/ph16091240 |
Ejemplares similares
-
PKHB1 peptide induces antiviral effects through induction of immunogenic cell death in herpes simplex keratitis
por: He, Yun, et al.
Publicado: (2022) -
Patient priorities in herpes simplex keratitis
por: Liu, Xiaoxuan, et al.
Publicado: (2019) -
Adoption of Innovation in Herpes Simplex Virus Keratitis
por: Chodosh, James, et al.
Publicado: (2020) -
Clinical Management of Herpes Simplex Virus Keratitis
por: Labib, Bisant A., et al.
Publicado: (2022) -
Immunological Aspects of Acute and Recurrent Herpes Simplex Keratitis
por: Rolinski, Jacek, et al.
Publicado: (2014)